Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Aprepitant 40 mg,People at high risk of post-operative nausea and vomiting,Aprepitant 40 mg,Options for investment,Hospital,Nervous System
